Investment Rating - The report does not explicitly provide an investment rating for the rare disease industry in China Core Insights - The rare disease sector in China is gaining significant attention, transitioning from a marginal field to a central topic in national policy, healthcare systems, and social awareness [3][5] - The number of rare diseases included in the national catalog has increased to 207, with 101 approved treatments available, enhancing drug accessibility for patients [3][25] - The establishment of a collaborative network for rare disease diagnosis has improved early diagnosis rates and standardized treatment levels [4][5] Summary by Sections Chapter 1: Overview of Rare Diseases - Rare diseases affect a significant global population, with estimates of 260 million to 450 million individuals impacted [18] - China has approximately 1,400 known rare diseases, with over 20 million patients [18][19] - The management of rare diseases in China is based on a catalog system, with two batches of rare disease catalogs published [21][25] Chapter 2: Current Status of Rare Disease Diagnosis and Treatment in China - The challenges faced by rare disease patients include a lack of effective treatments and insufficient healthcare coverage [33][34] - The average diagnosis time for rare diseases is approximately 4.26 years, with a high misdiagnosis rate of 42% among surveyed patients [36][40] - The number of approved rare disease drugs in China has increased, with 188 drugs available by the end of 2024 [40] Chapter 3: Current Status and Progress of Rare Disease Drug Coverage - The drug coverage system for rare diseases is evolving, with 126 drugs included in the national insurance scheme by the end of 2024 [40][41] - Various local initiatives, such as special funds and insurance models, are being explored to enhance drug accessibility for rare disease patients [4][41] Chapter 4: Development Trends in the Rare Disease Industry - Future trends in the rare disease sector will focus on innovation and collaboration, with advancements in gene and cell therapies expected [5] - The number of new rare disease drugs launched in China reached 29 in 2024, with 14 from domestic companies [11][12] - The global rare disease sector is becoming a hot investment area, with multinational pharmaceutical companies actively pursuing mergers and collaborations [12][37] Chapter 5: Outlook for Comprehensive Support Systems for Rare Diseases - The report emphasizes the need for a robust policy and legal framework to support rare disease management [40] - A multi-layered and sustainable payment system for rare disease treatments is essential for alleviating the financial burden on patients [41][42]

Investment Rating - The report does not explicitly provide an investment rating for the cloud service industry related to Chinese enterprises going abroad. Core Insights - Chinese enterprises are increasingly focusing on high-end industries such as smart manufacturing, healthcare, and finance as they expand internationally. Over 2,000 Chinese listed companies have entered overseas markets, representing over 50% of all listed companies in China. The trend is towards emerging markets, particularly Southeast Asia, Latin America, and regions in the Middle East and Africa [6][14][15]. Summary by Sections Market Overview - The report analyzes the characteristics, demand points, and development trends of cloud services used by Chinese enterprises going abroad. It also explores the competitive landscape of the outbound cloud service market and the differentiated competitive advantages of leading companies [3][4]. User Experience and Demand - A survey of downstream users from various sectors indicates that the core drivers for cloud adoption include compliance cost reduction, cross-border data flow, localization support, and ecosystem partner support. Concerns include data security, cloud costs, and vendor lock-in. Large enterprises prefer multi-cloud architectures, while SMEs focus on the flexibility and cost-effectiveness of cloud-native architectures [7][20]. Competitive Landscape - Cloud vendors that align with the technical needs and habits of outbound Chinese enterprises are more competitive. The ability to provide industry-specific solutions and expertise is crucial for cloud service selection. The report highlights the shift from initial collaboration to strategic partnerships between cloud vendors and ecosystem partners [8][34]. Technological Integration - The integration of AI into cloud-native designs is emphasized, with a focus on enhancing "intelligent-intensive" cloud services. Future cloud services will increasingly incorporate AI capabilities, improving operational efficiency for Chinese enterprises abroad [9][68]. Cloud Service Demand Characteristics - The report identifies key technical and operational demands from outbound Chinese enterprises. Technical needs include reliability, agility, usability, security, and intelligence, while operational needs focus on localized support, ecosystem collaboration, and sustainable development [19][26]. Future Trends - The report anticipates that outbound Chinese enterprises will prioritize flexibility, stability, risk diversification, and cost-effectiveness in their cloud service choices. There will be a growing focus on multi-cloud architectures, serverless architectures, and cloud-native high-availability architectures [25][29]. Ecosystem Development - The cloud service industry is moving towards an "intelligent upgrade" phase, emphasizing the importance of ecosystem collaboration. Cloud vendors are encouraged to enhance their local support capabilities globally, which is vital for outbound enterprises [61][63].

Investment Rating - The report does not explicitly state an investment rating for the hybrid and private cloud industry in China [1]. Core Insights - The hybrid and private cloud market is experiencing accelerated penetration across various sectors such as finance, government, manufacturing, healthcare, energy, and transportation, driving digital transformation and enhancing operational efficiency while meeting data security and compliance needs [8]. - The demand for localized deployment of private and hybrid cloud models is particularly strong due to policy compliance, security, and business requirements [3][5]. - The report highlights the increasing integration of AI-driven edge computing and localized deployment across industries, indicating a shift from traditional sectors like government and finance to emerging industries [5]. Summary by Sections Hybrid and Private Cloud Market Research Background - The hybrid and private cloud market is driven by multiple factors including internal demand, policy support, and technological advancements [3]. - The report covers the deployment services provided by IaaS and PaaS layers of hybrid and private cloud architectures [4]. Hybrid and Private Cloud in Government Sector - The government sector is defined as the public sector responsible for public policy execution and service provision [6]. - The application value and market share of hybrid and private cloud solutions in the government sector are analyzed [2]. Hybrid and Private Cloud in Financial Sector - The financial sector encompasses currency management, investment, banking, insurance, and other financial services [6]. - The report evaluates the application value and market share of hybrid and private cloud solutions in the financial sector [2]. Hybrid and Private Cloud in Manufacturing Sector - The manufacturing sector includes industries producing goods and materials such as electronics, steel, cement, and chemicals [6]. - The report discusses the application value and market share of hybrid and private cloud solutions in manufacturing [2]. Hybrid and Private Cloud in Transportation Sector - The transportation sector focuses on efficient movement of people and goods through various infrastructures [6]. - The report examines the application value and market share of hybrid and private cloud solutions in transportation [2]. Hybrid and Private Cloud in Energy Sector - The energy sector involves the production and supply of electricity, oil, gas, and renewable energy [6]. - The report analyzes the application value and market share of hybrid and private cloud solutions in the energy sector [2]. Hybrid and Private Cloud in Healthcare Sector - The healthcare sector provides clinical, pharmaceutical, medical device, and health-related services [6]. - The report evaluates the application value and market share of hybrid and private cloud solutions in healthcare [2].

Investment Rating - The report does not explicitly provide an investment rating for the AI Agent industry Core Insights - The report highlights the strategic significance and potential impact of AI Agents in the artificial intelligence sector, emphasizing the need for systematic industry insights for decision-makers, investors, and technology developers [2] Summary by Sections Annual Ranking of AI Agents - The report presents the 2024 Annual Ranking of AI Agents, showcasing the most popular agents, which are predominantly led by internet companies in the consumer market [5][8] - The top 10 most popular agents include platforms like Copilot Pro and ModelScopeGPT, reflecting a growing demand for intelligent and personalized solutions [6][8] Analysis of Popular Agents - The report indicates that 60% of the top agents are from internet technology companies, while 40% are from digital transformation service providers [9] - The consumer market (B2C) is identified as the main battleground for AI Agents, driven by increasing consumer reliance on digital solutions [10] Global Development Potential - The report identifies the top 10 Chinese agents with the most global development potential, highlighting the role of AI startups and digital transformation service providers in driving market growth [12][16] - AI startups account for 40% of the most promising agents, showcasing their agility and innovation in technology applications [18] Practical Applications of Agents - The report lists the top 10 most practical agents, emphasizing the rapid shift towards intelligent applications in customer service and office automation [21][24] - The demand for intelligent agents in business scenarios is expected to grow, particularly in enhancing operational efficiency and customer experience [26] Innovation in AI Agents - The report features the top 10 most innovative agents, noting that internet technology companies lead in infrastructure and platform innovation [28][31] - AI startups focus on deep technological innovations, filling niche market needs, while digital transformation service providers play a crucial role in helping traditional industries adapt [33] Commercial Value Potential - The report outlines the top 10 agents with the highest commercial value potential, emphasizing the importance of internet technology firms and AI startups in driving innovation and application implementation [35][39] - The demand for agent technology is projected to be concentrated in general applications and robotics, particularly in smart manufacturing and logistics automation [41][42]

Investment Rating - The report does not explicitly provide an investment rating for the pet pharmaceutical industry Core Insights - The Chinese pet pharmaceutical industry is experiencing significant growth driven by increasing pet ownership and heightened awareness of pet health among owners [7][12] - Domestic pet pharmaceuticals are becoming a cornerstone of the market, characterized by improved quality, innovation, and alignment with local market needs [58] - The market is projected to grow from 93.9 billion yuan in 2020 to 209.5 billion yuan by 2024, with a compound annual growth rate (CAGR) of 22.2% [55][57] Summary by Sections Chapter 1: The Golden Era of Pet Healthcare in China - The role of pets has evolved from mere companions to integral family members, leading to increased focus on their health [11][12] - Pet owners are willing to invest more in professional healthcare services, including high-quality medications and medical procedures [16] Chapter 2: The Rise of Domestic Pet Pharmaceuticals - Domestic pet pharmaceuticals are gaining traction due to enhanced quality and innovation, becoming a vital part of the pet healthcare market [58] - The internationalization of Chinese pet pharmaceuticals is underway, with companies meeting global standards for quality and safety [58] Chapter 3: Competition Among Domestic Pet Pharmaceutical Brands - The competitive landscape is marked by brands focusing on increasing offline store coverage, product variety, and pricing strategies [9][75] - The report highlights the importance of offline store presence as a key competitive factor in the domestic pet pharmaceutical market [75] Market Size and Growth - The pet pharmaceutical market in China is expected to reach 354.1 billion yuan by 2029, with a projected CAGR of 10.4% from 2025 to 2028 [55][57] - The number of pet clinics is anticipated to grow from 26,000 in 2024 to 44,000 by 2029, reflecting a CAGR of 10.4% [45][46] Domestic Brand Development - Domestic brands are increasingly recognized for their high cost-performance ratio, making them the preferred choice for veterinary institutions [69] - The report emphasizes the establishment of strong partnerships between domestic brands and veterinary clinics, enhancing service quality and brand loyalty [71][73]

Investment Rating - The report does not explicitly provide an investment rating for the industry Core Insights - The Chinese catering industry is the second largest in the world, with a market size exceeding 5 trillion RMB in 2023, and is expected to grow to 8.2 trillion RMB by 2028, driven by urbanization, digital platforms, and the rise of delivery services [9][14][18] - Chinese cuisine, particularly Sichuan and Hunan cuisine, dominates the market, with Hunan cuisine accounting for approximately 9% of the Chinese dining market in 2023 [11][29] - The report highlights the significant growth potential in the chain restaurant sector, which is expected to increase from 20.4% of total revenue in 2023 to 25.4% by 2028, indicating a shift towards more standardized and scalable operations [14][16] Summary by Sections Overview of the Chinese Catering Industry - The Chinese catering market is classified into various segments, with traditional Chinese dining holding a dominant position, accounting for nearly 80% of the market in 2023 [11][22] - The market is characterized by a large number of non-chain small businesses, leading to a fragmented landscape [13][14] Market Size and Growth - The Chinese catering market grew from 4.7 trillion RMB in 2019 to 5.3 trillion RMB in 2023, with a compound annual growth rate (CAGR) of 3.1% [14] - The Chinese Hunan cuisine market is projected to grow from 2.1 billion RMB in 2019 to 3.6 billion RMB by 2028, reflecting a CAGR of 9.4% [39] Trends in the Catering Industry - The report identifies a trend towards digitalization and retailing within the catering industry, with businesses adopting new technologies to enhance service capabilities and operational efficiency [17] - The rise of community dining and the focus on food safety are also highlighted as significant trends shaping the industry [18][19] Hunan Cuisine Market Analysis - Hunan cuisine is recognized for its unique flavor profile, primarily characterized by its spicy and aromatic dishes, and has seen a surge in popularity across various regions [25][29] - The market for Hunan cuisine is expected to continue expanding, particularly in new first-tier cities and beyond [38][41] Competitive Landscape - The competitive landscape is becoming increasingly intense, with major brands focusing on chain operations and standardized offerings to enhance market presence [34][35] - Successful brands in the Hunan cuisine sector are leveraging supply chain management and quality control to maintain consistency and customer satisfaction [31][32] Future Outlook - The report anticipates that the Hunan cuisine market will continue to grow, driven by improved supply chain systems, brand recognition, and the expansion of chain restaurants [38][39] - The potential for further market consolidation and the emergence of new dining formats are also expected to shape the future of the industry [18][19]

Investment Rating - The report does not explicitly state an investment rating for the collagen industry. Core Insights - The collagen market in China is experiencing unprecedented growth, driven by increasing consumer awareness of its health and beauty benefits, leading to sustained demand [63]. - The medical and aesthetic applications of collagen are expanding, with significant advancements in technology enhancing its effectiveness and safety [31][32][87]. - The report highlights the importance of regulatory approvals for collagen medical devices, indicating a growing market with stringent safety and efficacy requirements [41][66]. Summary by Sections Chapter 1: Overview of Collagen - Collagen is a key structural protein in multicellular organisms, constituting about 30% of total protein in the human body [2]. - Different types of collagen exist, each serving specific functions in various tissues, such as skin, bones, tendons, and cartilage [17]. - The extraction of collagen involves removing impurities from raw materials, which can include proteins, polysaccharides, fats, and minerals [12][23]. Chapter 2: Applications of Collagen - Collagen is widely used in the medical field for its mechanical properties, aiding in tissue repair and regeneration [31]. - In aesthetic medicine, modified collagen products are used for injections to improve skin quality and reduce wrinkles, with several products approved for dermal injection in China [33]. - Collagen's role in skincare products is significant, as it provides moisturizing and repairing benefits, leading to increased demand for functional skincare products [35][58]. Chapter 3: Market Analysis of Collagen - The collagen market in China is projected to grow significantly, with rising consumer acceptance of medical aesthetics and post-operative recovery products [64]. - As of November 2024, nearly a thousand collagen medical device products have been approved in China, indicating a robust regulatory environment [41]. - The report notes that the approval process for Class III medical devices is stringent, with only about 40 collagen products achieving this status, highlighting the challenges in the market [66].

Industry Overview - The global off-grid power storage equipment industry is divided into two main categories: portable energy storage and home energy storage [13] - Portable energy storage devices typically have a battery capacity ranging from 500Wh to 3000Wh, while home energy storage devices range from 3000Wh to 6000Wh [13] - The industry is driven by factors such as technological advancements, expanding application scenarios, and increasing demand for high-capacity products [146][147] Market Trends - The rise of outdoor activities and frequent natural disasters have increased demand for portable energy storage devices [22] - Home energy storage is becoming a new growth point, especially in regions with high electricity costs like Europe and North America [37] - The market is highly competitive, with Chinese companies like Ecoflow, Jackery, Anker, and Bluetti dominating the portable energy storage sector [36] Key Players - Jackery (华宝新能) leads in lightweight and compact designs, with products like the Explorer 1000 V2 and Explorer 2000 V2 being the smallest and lightest in their respective categories [64][69] - Ecoflow (正浩创新) focuses on high-capacity solutions, offering products like the Delta 2 Max and Delta 3 Plus for both portable and home energy storage [43] - Bluetti (德兰明海) has expanded from portable to home energy storage, with products like the AC500 and EP500 series [43] Product Analysis - Portable energy storage devices with capacities around 1kWh and 2kWh are popular for outdoor activities, with Jackery's Explorer series leading in weight and volume efficiency [64][69] - Home energy storage devices typically start at 3kWh, with Jackery's Explorer 5000 Plus being the lightest and most compact in the 5kWh category [115] - Solar charging kits, combining energy storage devices with solar panels, are gaining traction, with Jackery's SG2000V2 and SG3000V2 being the lightest and most compact in their categories [119][137] Technological Advancements - Lithium-ion battery technology has improved significantly, with higher energy density and safety, making it the preferred choice for off-grid energy storage [146][147] - The integration of solar panels with energy storage devices has enhanced the efficiency and convenience of portable and home energy solutions [29][120] Future Outlook - The industry is expected to benefit from declining raw material costs, increasing penetration rates, and the expansion of home energy storage [163][164][168] - Government policies, both domestic and international, are supporting the growth of the energy storage industry, with incentives for home energy storage systems [169][170]

沙利文联合头豹研究院谨此发布中国生成式式AI系列报告之《2024年中 国GenAI技术栈市场报告》。本报告旨在梳理GenAI技术栈的市场发展现 状、技术栈核心组件、用户核心需求以及相关技术洞察，明晰市场需求， 并结合市场发展前景判断GenAI技术栈领域内各类竞争者所处地位。 2024年中国GenAI技术栈 市场报告 ---------- 本市场报告提供的GenAI技术栈发展趋势分析反映出生成式AI行业整体 的动向。报告最终对市场排名、领袖梯队的判断仅适用于本年度中国 GenAI技术栈领域发展周期。 报告提供的任何内容（包括但不限于数据、文字、图表、图像等）均系弗若斯特 沙利文及头豹研究院独有的高度机密性文件（在报告中另行标明出处者除外）。 未经弗若斯特沙利文及头豹研究院事先书面许可，任何人不得以任何方式擅自复 制、再造、传播、出版、引用、改编、汇编本报告内容，若有违反上述约定的行 为发生，弗若斯特沙利文及头豹研究院保留采取法律措施、追究相关人员责任的 权利。弗若斯特沙利文及头豹研究院开展的所有商业活动均使用"弗若斯特沙利 文"、"沙利文"、"头豹研究院"或"头豹"的商号、商标，弗若斯特沙利文 及头豹研究院无任 ...

⼤国品牌竞争⼒发展报告 | 《⼤国品牌》传播是⼀种品牌影响⼒投资 ⼤国品牌竞争⼒ 发展报告 Great Brand Competitiveness Development Report 科学创新引领品牌未来 · ⼤国品牌传播是影响⼒投资 www.frostchina.com ©2024弗若斯特沙利⽂ ⼤国品牌竞争⼒发展报告 | 《⼤国品牌》传播是⼀种品牌影响⼒投资 ⼤国品牌竞争⼒发展报告 | 《⼤国品牌》传播是⼀种品牌影响⼒投资 2 企业家和学者寄语 "随着中国经济的快速发展和对外开放的深化，中国品牌出海已成为国家战略的重要篇章，众多企业积 极将品牌推向世界舞台。沙利⽂从'⼤'、'国'、'品'、'牌'四个维度深⼊探讨了'⼤国品牌'的核⼼内涵。《⼤国 品牌竞争⼒发展报告》揭示了品牌建设与国家发展的深刻联系，旨在通过科学创新为品牌提供最前沿的洞 察与策略指导。随着'⼀带⼀路'倡议等国家战略的推进，中国企业家迎来了前所未有的机遇。这份报告指引 并激励企业家们利⽤品牌⼒量讲述中国故事，传递中国价值，在全球范围内建⽴强⼤的品牌形象。" －－王昕博⼠ 沙利⽂ 全球合伙⼈兼⼤中华区董事⻓ "在中国从⾼速发展迈向⾼质量发展的 ...